Lipid and lipoprotein dysregulation in insulin resistant states.
about
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistanceIdentification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolismInteraction between Glucose and Lipid Metabolism: More than Diabetic DyslipidemiaLipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approachesTranslational control mechanisms in metabolic regulation: critical role of RNA binding proteins, microRNAs, and cytoplasmic RNA granulesInsulin signaling regulates fatty acid catabolism at the level of CoA activationFoxO1 mediates insulin-dependent regulation of hepatic VLDL production in miceThe characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population.APOB-516 T allele homozygous subjects are unresponsive to dietary changes in a three-month primary intervention study targeted to reduce fat intake.Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiRSerum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular eventsMechanisms and significance of liver steatosis in hepatitis C virus infectionHigh-fat diet leads to tissue-specific changes reflecting risk factors for diseases in DBA/2J mice.Aqueous extract of post-fermented tea reverts the hepatic steatosis of hyperlipidemia rat by regulating the lipogenic genes expression and hepatic fatty acid compositionPlant sterols, marine-derived omega-3 fatty acids and other functional ingredients: a new frontier for treating hyperlipidemia.[Physical exercise as treatment of type 2 diabetes mellitus].Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liverAssessment of preoperative exercise capacity in hepatocellular carcinoma patients with chronic liver injury undergoing hepatectomy.Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity.Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentEffect of different exercise intensities on the pancreas of animals with metabolic syndromeNovel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats.Identification of differentially expressed genes related to metabolic syndrome induced with high-fat diet in E3 ratsDiabetes and hypertension: is there a common metabolic pathway?Insulin resistance, metabolic stress, and atherosclerosis.Myocardial Fat Accumulation Is Independent of Measures of Insulin Sensitivity.Effect of intensive vs conventional insulin therapy on perioperative nutritional substrates metabolism in patients undergoing gastrectomy.Gene Polymorphisms of FABP2, ADIPOQ and ANP and Risk of Hypertriglyceridemia and Metabolic Syndrome in Afro-Caribbeans.Ergosterol Alleviates Kidney Injury in Streptozotocin-Induced Diabetic MiceInjury-induced insulin resistance in adipose tissueAntidiabetic Activity of Polysaccharides from Tuberous Root of Liriope spicata var. prolifera in KKAy MiceClinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsEffects of perilipin (PLIN) gene variation on metabolic syndrome risk and weight loss in obese children and adolescentsAssociation of Serum Apolipoprotein B with the Increased Risk of Diabetes in Korean Men.Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.FoxO1 integrates insulin signaling to VLDL production.Nanoparticles as biochemical sensorsThe many intersecting pathways underlying apolipoprotein B secretion and degradationThe ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials
P2860
Q24648189-553DFC3B-DC3A-484C-8833-C38F5A997484Q24650184-7BCC535F-56B0-4314-AED8-41C638E57C44Q26777184-ACDEB53C-894B-4078-8C4A-EDA21B848455Q26866207-C93C924F-C65F-4B67-BFD4-863B97E2C268Q27022700-8903F3AA-6BA2-4FC8-9095-779F41401140Q27334898-86E99872-FC3B-46F5-AB1C-9FAA2CA420E9Q28507512-6F07E262-6065-4057-BE1F-71F4624A2E84Q33541335-6687C289-239A-4E88-BCA6-E99FCFF1F722Q33645996-80342CED-6DE6-46D4-BD3C-F2DA6CEFD280Q33661920-87AD9751-97B7-4A08-BE5E-962B45E306C5Q33812634-E9C4CE55-6150-490C-A167-33291B7B26C0Q33866272-33CD4911-A33A-4046-9E82-0BDC19B13CABQ33924894-9B6EDC10-E2E7-453D-A269-6B60761A2CC2Q34006718-8EE65019-9E28-42AF-90C7-E2F43DE4FCAEQ34199028-9B7DF817-4ADF-4701-B635-639CBEDCB0E6Q34268543-2A85C4D7-624D-4C34-8C84-3760E443D5F2Q34728811-E669987A-0FE9-448E-B9A1-4C8C151FD24BQ34856251-2B203ED6-7F1F-4400-8B82-3F4860D03202Q34929006-AC9C69A6-1998-40EE-8327-D6AEC71BD80CQ35029623-482EBCC5-836D-4833-B509-F57474FC6800Q35105171-BCD09D29-8172-4E5D-87E5-5AE3A67C1B15Q35106778-1E522962-630E-4B89-87AF-989C31F6AB74Q35311680-76E08FBA-0EE3-44F3-960B-1D5862AC751FQ35857205-89B23065-2BF8-47F9-8538-B3FA0F2926D4Q35871387-F0D43BF8-CA76-4CC0-8E3E-897B6679B817Q35916565-045BAC1C-32D0-4F05-9E04-8F2606CFE636Q36016062-67F8EB25-0F80-41A3-9AB5-B0CFCF1D7AD3Q36148177-EE8E7F0D-20D7-4CEF-AD3F-F26130904C37Q36333174-456329D3-8520-440F-A1F5-CA697FD19CF2Q36676216-4F6D815B-0085-4E2A-9101-8C36885001FEQ36916161-4B424495-C888-445E-B6A8-6F41B916016DQ37011769-90828333-EEB0-4DFB-A47A-8DD844F04116Q37061269-0CD99C4F-172E-41E6-A80A-C059B4AF8709Q37140846-5736403F-DB99-4C68-9691-BECDFEFB6218Q37143361-FA5E28BE-7C0D-4DF6-B552-26C83F9CB7B5Q37148966-5255E3DB-DC42-452D-AB66-906FB53F125DQ37194013-31D6E4BA-9C7B-4054-A3CE-D7CDA3E224FCQ37240302-DF916C0D-5CB6-4F9B-A0E4-AA903A061023Q37339542-7F89142B-148A-44FE-A727-CC3AF1A0249BQ37364089-421A6289-AFF9-4B28-B276-578F350E10A7
P2860
Lipid and lipoprotein dysregulation in insulin resistant states.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Lipid and lipoprotein dysregulation in insulin resistant states.
@ast
Lipid and lipoprotein dysregulation in insulin resistant states.
@en
type
label
Lipid and lipoprotein dysregulation in insulin resistant states.
@ast
Lipid and lipoprotein dysregulation in insulin resistant states.
@en
prefLabel
Lipid and lipoprotein dysregulation in insulin resistant states.
@ast
Lipid and lipoprotein dysregulation in insulin resistant states.
@en
P2093
P1433
P1476
Lipid and lipoprotein dysregulation in insulin resistant states.
@en
P2093
Heather Basciano
Khosrow Adeli
Rita Kohen Avramoglu
P356
10.1016/J.CCA.2005.12.026
P577
2006-02-09T00:00:00Z